Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is a Post-Market Surveillance study in Korea to evaluate the safety and efficacy
of dexamethasone 700 ㎍ (OZURDEX®) intravitreal implant used to treat Branch Retinal Vein
Occlusion, Central Retinal Vein Occlusion, or non-infectious uveitis affecting the posterior
segment of the eye in clinical practice.